Generic Drug Stocks List

Generic Drug Stocks Recent News

Date Stock Title
May 8 PRGO Perrigo First Quarter 2024 Earnings: EPS: US$0.03 (vs US$0.008 loss in 1Q 2023)
May 7 PRGO Perrigo Company plc (PRGO) Q1 2024 Earnings Call Transcript
May 7 PRGO Perrigo Company plc 2024 Q1 - Results - Earnings Call Presentation
May 7 PRGO Perrigo (PRGO) Q1 Earnings Surpass, Sales Miss Estimates
May 7 PRGO Perrigo (PRGO) Reports Q1 Earnings: What Key Metrics Have to Say
May 7 PRGO Perrigo Co PLC (PRGO) Q1 2024 Earnings: Adjusted EPS Exceeds Expectations Despite Sales Dip
May 7 PRGO Perrigo Non-GAAP EPS of $0.29, revenue of $1.08B
May 7 PRGO Perrigo Reports First Quarter 2024 Financial Results From Continuing Operations
May 7 PRGO Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) Business
May 6 AMRX Amneal Pharmaceuticals First Quarter 2024 Earnings: US$0.30 loss per share (vs US$0.046 loss in 1Q 2023)
May 6 PRGO Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
May 6 PRGO Perrigo Q1 2024 Earnings Preview
May 6 PRGO Insights Into Perrigo (PRGO) Q1: Wall Street Projections for Key Metrics
May 4 PRGO Perrigo (NYSE:PRGO) Is Due To Pay A Dividend Of $0.276
May 4 AMRX Amneal Pharmaceuticals Inc (AMRX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
May 3 AMRX Amneal stock climbs on Q1 report, opioid settlement update
May 3 AMRX Amneal Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 3 AMRX Amneal Pharmaceuticals, Inc. (AMRX) Q1 2024 Earnings Call Transcript
May 3 AMRX Amneal Pharmaceuticals Non-GAAP EPS of $0.14 beats by $0.05, revenue of $659M beats by $39.97M
May 3 AMRX Amneal Reports First Quarter 2024 Financial Results
Generic Drug

Generic drugs are medications that have the same active ingredients as their brand-name counterparts, but are typically sold at a lower cost. Generic drugs are typically less expensive than brand-name drugs because the manufacturers do not have to invest in research and development to create the drug. Generic drugs are also subject to the same standards of safety, quality, and efficacy as brand-name drugs.

Browse All Tags